DHR:NYE-Danaher Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 246.58

Change

0.00 (0.00)%

Market Cap

USD 54.15B

Volume

2.68M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corp designs, manufactures & markets professional, medical, industrial & commercial products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
TMO Thermo Fisher Scientific Inc

+15.10 (+2.61%)

USD 218.67B
A Agilent Technologies Inc

+4.62 (+3.18%)

USD 43.89B
IQV IQVIA Holdings Inc

+4.88 (+2.13%)

USD 42.75B
MTD Mettler-Toledo International I..

+219.83 (+17.04%)

USD 26.69B
WAT Waters Corporation

+14.69 (+4.37%)

USD 19.21B
LH Laboratory Corporation of Amer..

+1.52 (+0.74%)

USD 17.09B
DGX Quest Diagnostics Incorporated

+0.26 (+0.19%)

USD 14.27B
RVTY Revvity Inc.

+0.46 (+0.44%)

USD 12.54B
CRL Charles River Laboratories

-1.97 (-0.86%)

USD 11.85B
QGEN Qiagen NV

+0.03 (+0.07%)

USD 9.22B

ETFs Containing DHR

AILG 6.99 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 6.69 % 0.00 %

+0.08 (+0%)

USD 5.43M
DXSF:XETRA Xtrackers - Stoxx Europe .. 5.91 % 0.00 %

+0.49 (+0%)

USD 0.08B
LIFE-B:CA Evolve Global Healthcare .. 5.38 % 0.00 %

+0.07 (+0%)

CAD 0.01B
LIFE-U:CA Evolve Global Healthcare .. 5.22 % 0.00 %

+0.23 (+0%)

N/A
ZWHC:CA BMO Covered Call Health C.. 4.59 % 0.00 %

+0.07 (+0%)

CAD 0.01B
XGES:LSE Xtrackers MSCI Genomic He.. 4.47 % 0.00 %

+0.13 (+0%)

USD 3.48M
YALL God Bless America ETF 4.47 % 0.00 %

+0.05 (+0%)

USD 0.07B
BCHP 4.44 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.39 % 0.00 %

+0.20 (+0%)

USD 0.15B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.33 % 0.00 %

+0.15 (+0%)

USD 3.48M
SANE 3.95 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 3.49 % 0.00 %

-0.04 (0%)

USD 0.02B
XUHC:F Xtrackers (IE) Public Lim.. 3.23 % 0.00 %

+0.16 (+0%)

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 3.23 % 0.00 %

+0.36 (+0%)

USD 0.85B
XSHC:LSE Xtrackers MSCI USA Health.. 3.21 % 0.00 %

+31.00 (+0%)

USD 1.04B
XUHC:LSE Xtrackers MSCI USA Health.. 3.21 % 0.00 %

+0.34 (+0%)

USD 1.04B
ZPDH:F SPDR S&P U.S. Health Care.. 3.12 % 0.00 %

+0.18 (+0%)

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 3.12 % 0.00 %

+0.28 (+0%)

USD 0.40B
GXLV:LSE SPDR® S&P® U.S. Health .. 3.12 % 0.00 %

+0.22 (+0%)

USD 0.38B
IHCU:LSE iShares S&P 500 Health Ca.. 3.12 % 0.00 %

+5.50 (+0%)

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 3.12 % 0.00 %

+0.07 (+0%)

USD 2.07B
QDVG:F iShares S&P 500 Health Ca.. 3.12 % 0.00 %

+0.04 (+0%)

USD 2.09B
QDVG:XETRA iShares S&P 500 Health Ca.. 3.12 % 0.00 %

+0.07 (+0%)

USD 2.05B
XUHC:SW Xtrackers MSCI USA Health.. 3.10 % 0.00 %

+0.41 (+0%)

USD 0.13M
IUHC:SW iShares S&P 500 Health Ca.. 3.00 % 0.00 %

+0.13 (+0%)

USD 2.20B
SXLV:SW SPDR S&P U.S. Health Care.. 2.99 % 0.00 %

+0.47 (+0%)

N/A
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.76 % 0.00 %

+0.74 (+0%)

N/A
DRUP GraniteShares ETF Trust -.. 2.74 % 0.00 %

+0.29 (+0%)

USD 0.06B
USRI:PA AMUNDI MSCI USA SRI Clima.. 2.72 % 0.00 %

+0.69 (+0%)

USD 3.48B
UBUS:F UBS (Irl) ETF Public Limi.. 2.53 % 0.00 %

+0.15 (+0%)

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 2.53 % 0.00 %

+0.15 (+0%)

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

+0.21 (+0%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

+0.16 (+0%)

USD 0.05B
USRI:LSE 2.50 % 0.00 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.50 % 0.00 %

+16.00 (+0%)

USD 0.35B
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.45 % 0.00 %

+0.41 (+0%)

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.45 % 0.00 %

+0.28 (+0%)

USD 0.32B
UPVLH:SW 2.45 % 0.00 %

N/A

N/A
CURE Direxion Daily Healthcare.. 2.43 % 1.06 %

+0.82 (+0%)

USD 0.19B
DSAE:CA Desjardins SocieTerra Ame.. 2.21 % 0.00 %

+0.09 (+0%)

CAD 1.13M
SUAP:LSE iShares MSCI USA SRI UCIT.. 2.10 % 0.00 %

+0.03 (+0%)

USD 0.06B
SUUS:LSE iShares Sustainable MSCI .. 2.10 % 0.00 %

+5.00 (+0%)

USD 6.01B
SUAS:LSE iShares Sustainable MSCI .. 2.10 % 0.00 %

+0.07 (+0%)

USD 6.01B
36B6:F iShares MSCI USA SRI UCIT.. 2.08 % 0.00 %

+0.05 (+0%)

N/A
3SUR:F iShares IV Public Limited.. 2.08 % 0.00 %

+5.80 (+0%)

N/A
QDVR:F iShares MSCI USA SRI UCIT.. 2.08 % 0.00 %

+0.06 (+0%)

USD 7.94B
3SUR:XETRA iShares MSCI USA SRI UCIT.. 2.08 % 0.00 %

+8.20 (+0%)

USD 0.40B
QDVR:XETRA iShares MSCI USA SRI UCIT.. 2.08 % 0.00 %

+0.07 (+0%)

USD 7.22B
SUAS:SW iShares MSCI USA SRI UCIT.. 2.01 % 0.00 %

N/A

USD 6.04B
XAMB:F Amundi Index Solutions - .. 1.53 % 0.00 %

+0.39 (+0%)

N/A
HYLG Global X Funds - Global X.. 1.44 % 0.00 %

+0.03 (+0%)

USD 2.85M
MWSH:XETRA Amundi MSCI World SRI Cli.. 1.41 % 0.00 %

+0.49 (+0%)

USD 4.92B
WGES:XETRA Amundi MSCI World SRI Cli.. 1.41 % 0.00 %

+0.11 (+0%)

USD 4.53B
WESE:PA Lyxor MSCI World ESG Lead.. 1.41 % 0.00 %

+0.33 (+0%)

N/A
WSRI:PA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

+0.58 (+0%)

USD 4.32B
XAMB:XETRA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

+0.54 (+0%)

USD 4.92B
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
SUWS:LSE iShares MSCI World SRI UC.. 1.28 % 0.00 %

+0.04 (+0%)

USD 1.61B
WELA:XETRA Amundi MSCI ACWI SRI PAB .. 1.17 % 0.00 %

+0.08 (+0%)

USD 0.08B
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

+0.08 (+0%)

USD 0.08B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

+0.03 (+0%)

USD 2.94B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.20 (+0%)

USD 3.92B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.01 (+0%)

USD 3.23B
JHMH 0.00 % 0.46 %

N/A

N/A
PHO Invesco Water Resources E.. 0.00 % 0.60 %

+0.31 (+0%)

USD 2.07B
PIO Invesco Global Water ETF 0.00 % 0.75 %

+0.15 (+0%)

USD 0.28B
RAVI FlexShares Ready Access V.. 0.00 % 0.25 %

+0.01 (+0%)

USD 1.14B
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

+0.11 (+0%)

CAD 0.05B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.36 (+0%)

CAD 0.05B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
HWF:CA 0.00 % 0.00 %

N/A

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.11 (+0%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.49 (+0%)

USD 0.09B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+0.14 (+0%)

USD 16.98B
XLV Health Care Select Sector.. 0.00 % 0.13 %

+0.29 (+0%)

USD 37.76B
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

+0.03 (+0%)

CAD 0.33B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.03 (+0%)

CAD 0.01B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.25 (+0%)

USD 0.38B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+9.00 (+0%)

USD 8.21M
GNAR:F 0.00 % 0.00 %

N/A

N/A
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
XOUT GraniteShares XOUT U.S. L.. 0.00 % 0.00 %

N/A

USD 0.06B
ANEW ProShares MSCI Transforma.. 0.00 % 0.00 %

-0.03 (0%)

USD 7.77M
JSTC Tidal ETF Trust - Adasina.. 0.00 % 0.00 %

+0.03 (+0%)

USD 0.16B
VNSE Natixis ETF Trust II - Na.. 0.00 % 0.00 %

-0.01 (0%)

USD 0.03B
36B6:XETRA iShares MSCI USA SRI UCIT.. 0.00 % 0.00 %

+0.05 (+0%)

USD 7.58B
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.04 (+0%)

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.01 (+0%)

CAD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.59% 79% B- 74% C
Dividend Return 0.12% 29% F 4% F
Total Return 6.70% 79% B- 71% C-
Trailing 12 Months  
Capital Gain 4.08% 83% B 49% F
Dividend Return 0.44% 33% F 4% F
Total Return 4.52% 83% B 40% F
Trailing 5 Years  
Capital Gain 87.77% 91% A- 86% B+
Dividend Return 3.34% 60% D- 11% F
Total Return 91.11% 91% A- 85% B
Average Annual (5 Year Horizon)  
Capital Gain 16.38% 67% D+ 81% B-
Dividend Return 16.78% 67% D+ 80% B-
Total Return 0.40% 67% D+ 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 29.39% 58% F 38% F
Risk Adjusted Return 57.08% 75% C 81% B-
Market Capitalization 54.15B 92% A 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.10 33% 14%
Price/Book Ratio 3.38 62% 25%
Price / Cash Flow Ratio 25.42 38% 11%
Price/Free Cash Flow Ratio 25.96 8% 9%
Management Effectiveness  
Return on Equity 8.15% 38% 50%
Return on Invested Capital 6.92% 43% 52%
Return on Assets 3.98% 38% 64%
Debt to Equity Ratio 31.24% 69% 72%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.